跳至主要内容
临床试验/NCT05103722
NCT05103722终止不适用

A Pilot Study of Combined Aerobic and Resistance Exercise Training in Metastatic Renal Cell Carcinoma

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2022年2月17日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
2
试验地点
2
主要终点
Number of participants who adhere to the exercise intervention

研究概览

简要总结

The trial studies the effects of personalized home-based aerobic and resistance exercises on quality of life, changes in physical activity levels, and the change in inflammatory myokines with the exercise intervention in Interleukin 6 (IL-6), C-reactive Protein (CRP), Leptin, Transforming growth factor beta (TGF-beta), and Interferon (INF) gamma.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Histologically confirmed diagnosis of RCC
  • Patients being treated with standard of Programmed cell death protein 1 (anti-PD-1) or anti-PD-L1 immune-checkpoint inhibitor-containing standard of care regimen including patients who are about to start treatment or have been on treatment for a maximum of 4 weeks prior to signing consent
  • Metastatic Measurable disease, as defined by RECIST 1.1
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 with a life expectancy ≥ six months
  • Physically able to enroll in the exercise program as determined by the treating medical oncologist and after review by Physical medicine and rehabilitation physicians at Johns Hopkins
  • Adequate bone marrow reserve and organ function measured within 28 days prior to administration of study treatment with the following key parameters:
  • Hematological:
  • Absolute neutrophil count ≥ 1.5 × 109/L
  • Platelets ≥ 100 × 109/L
  • Hemoglobin≥ 9.0 g/dL
  • Serum Creatinine ≤ 1.5 x the upper limit of normal (ULN) or Calculated Creatinine clearance ≥ 30mL/min
  • Total bilirubin ≤ 1.5 x ULN (Patients with known Gilbert disease who have serum bilirubin level ≤ 3 x ULN may be enrolled)
  • Serum Aspartate aminotransferase (AST) and serum Alanine aminotransferase (ALT) ≤ 2.5 x ULN (For patients with documented liver metastases AST and/or ALT ≤ 5 x ULN)

排除标准

  • The presence of bone metastasis in the spine, pelvis, and lower limbs
  • Currently physically active or moderately active as determined by Leisure Score Index of Godin Leisure-Time Exercise Questionnaire (GSLTPAQ)
  • History of underlying cardiovascular, respiratory, musculoskeletal disease or joint problems that preclude moderate physical activity
  • Known underlying uncontrolled brain metastatic lesions requires steroids therapy and/or radiotherapy
  • Major surgery within four weeks prior to enrollment.
  • Radiotherapy for RCC 28 days prior to week 1 day 1

结局指标

主要结局

Number of participants who adhere to the exercise intervention

时间窗: 2 years

次要结局

  • Change in HRQoL as measured by FACT-G Questionnaire(Baseline, Week 4, Week 8, Week 12 and Week 24)
  • The incidence of grade 3-5 toxicities as per CTCAE 5.0(2 years)
  • Percentage of patients who remained in the study and didn't drop off the study after enrollment(2 years)
  • Percentage of patients screened compared to patients enrolled(2 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Combined Aerobic and Resistance Exercise Training in... | 临床试验